US 9173880
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies
granted A61KA61K2039/505A61K31/485
Quick answer
US patent 9173880 (Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Nov 03 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 29 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/505, A61K31/485, A61K39/3955, A61K47/183